The Journal of Pediatrics
Volume 151, Issue 1 , Pages 6-7 , July 2007

Respiratory Syncytial Virus Infection and Recurrent Wheezing: A Complex Relationship

  • H. Cody Meissner, MD

      Affiliations

    • Division of Pediatric Infectious Disease, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts
    • Corresponding Author InformationReprint requests: H. Cody Meissner, MD, Pediatric Infectious Disease Division, Tufts-New England Medical Center, 750 Washington St, Boston, MA 02111.
    • ,
  • Sarah S. Long, MD

      Affiliations

    • Section of Infectious Disease, St Christopher’s Hospital for Children, Drexel University College of Medicine, Philadelphia, Pennsylvania

Received 16 January 2007 ,Accepted 9 February 2007.

References 

  1. Hall CB, McCarthy CA. Respiratory syncytial virus. In: Mandell , Bennett , Dolin  editor. Principles and practice of infectious diseases. 6th ed.. Philadelphia: Elsevier Churchill Livingstone; 2005;p. 2009–2027
  2. Welliver RC. RSV and other respiratory viruses. Pediatr Infect Dis J. 2003;22:S6–S12
  3. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson children’s respiratory study: 1980 to present. J Allergy Clin Immunol. 2003;111:661–675
  4. Korppi M, Kotaniemi-Syrjanen A, Waris M, Vainionpaa R, Reijonen TM. Rhinovirus associated wheezing in infancy. Pediatr Infect Dis J. 2004;23:995–999
  5. Lemanske RF. Viruses and asthma: inception, exacerbation, and possible prevention. J Pediatr. 2003;142:S3–S8
  6. Eriksson M, Bennet R, Nilsson A. Wheezing following lower respiratory tract infections with RSV and influenza A in infancy. Pediatr Allergy Immunol. 2000;11:193–197
  7. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, et al. RSV in early life and risk of wheeze and allergy by 13 years. Lancet. 1999;354:541–545
  8. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe RSV bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171:137–141
  9. Martinez FD. Heterogeneity of the association between lower respiratory illness in infancy and subsequent asthma. Proc Am Thorac Soc. 2005;2:157–161
  10. Simoes EAF, Groothuis JR, Carbonell-Estrany X, Rieger CHL, Mitchell I, Fredrick LM, et al. Palivizumab prophylaxis, RSV and subsequent recurrent wheezing. J Pediatr. 2007;151:34–42
  11. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis associated hospitalizations among United States children, 1980-1996. JAMA. 1999;282:1440–1446
  12. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization and mortality. Pediatrics. 2002;110:315–322
  13. IMPACT-RSV study group. Palivizumab, a humanized RSV monoclonal antibody, reduces hospitalization from RSV infection in high risk infants. Pediatrics. 1998;102:531–537
  14. Collins PL, Murphy BR. New generation live vaccines against human RSV designed by reverse genetics. Proc Am Thorac Soc. 2005;2:166–173
  15. AAP (Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections). Pediatrics. 2003;112:1442–1446

PII: S0022-3476(07)00169-2

doi: 10.1016/j.jpeds.2007.02.034

The Journal of Pediatrics
Volume 151, Issue 1 , Pages 6-7 , July 2007

Article Tools